跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

Equity Commonwealth (EQC) Stock Forecast 2025 - AI Price Prediction & Analysis

Equity Commonwealth (EQC) AI Stock Price Forecast & Investment Analysis

Equity Commonwealth Stock Price Chart and Technical Analysis

Loading Equity Commonwealth interactive price chart and technical analysis...

Equity Commonwealth (EQC) - Comprehensive Stock Analysis & Investment Research

Deep dive into Equity Commonwealth's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Equity Commonwealth, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Equity Commonwealth: Equity Commonwealth operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

Equity Commonwealth (Stock Symbol: EQC) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 33 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Equity Commonwealth's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Equity Commonwealth: With $58M in annual revenue and 85.4% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $58 million generating a 85.4% net profit margin .

Market Capitalization: $177 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -0.4% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Equity Commonwealth stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Equity Commonwealth: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Equity Commonwealth stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Equity Commonwealth's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Equity Commonwealth: Strong free cash flow generation demonstrates developing operational efficiency.

Equity Commonwealth strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $17 million annually, complemented by impressive -66.3% year-over-year cash flow growth.

The company maintains a healthy 146.6% gross margin, indicating strong pricing power and operational efficiency.

Equity Commonwealth (EQC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Equity Commonwealth stock analysis.

Loading Equity Commonwealth comprehensive fundamental analysis and insider trading data...

Deep dive into Equity Commonwealth's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Equity Commonwealth stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Equity Commonwealth: With a P/E ratio of 2.32, the market sees the stock as potentially undervalued.

P/E Ratio 2.32x
P/B Ratio 0.07x
Market Cap $177M
EPS $0.18
Book Value/Share $22.32
Revenue/Share $0.05
FCF/Share $0.45
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Equity Commonwealth converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Equity Commonwealth: An ROE of -0.4% indicates room for improvement in shareholder value creation.

ROE -0.4%
ROA -0.4%
ROIC -0.6%
Gross Margin 146.6%
Operating Margin -9.1%
Net Margin 85.4%
EBT Margin -8.3%
Tax Rate 0.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Equity Commonwealth's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Equity Commonwealth: A current ratio of 138.60 indicates strong liquidity.

Current Ratio 138.60x
Quick Ratio 138.60x
D/E Ratio 0.01x
Financial Leverage 1.05x
Interest Coverage 730.6x
Working Capital $2967M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Equity Commonwealth's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Equity Commonwealth: Free cash flow of $17M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $17M
Free Cash Flow $17M
Capital Spending $-868M
OCF Growth YoY -66.3%
FCF Growth YoY -66.3%
FCF/Sales 29.2%
CapEx/Sales 95.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Equity Commonwealth uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Equity Commonwealth: An asset turnover of 0.02x suggests room for improvement in asset utilization.

Asset Turnover 0.02x
Receivables Turnover 4.0x
Fixed Assets Turnover 0.2x
Days Sales Outstanding 92 days
Payables Period 280 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Equity Commonwealth's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Equity Commonwealth: With annual revenue of $58M, Equity Commonwealth represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $58M
Operating Income $-5M
Net Income $49M
SG&A Expense $50M
Cost of Goods Sold $40M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 91%
Cash & Short-term Investments 91%
Total Liabilities 1%
Accounts Receivable 1%
Dividend & Shareholder Information
Shares Outstanding 107M
Growth Metrics (YoY)
EPS Growth 10.8%

Latest Equity Commonwealth Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Equity Commonwealth (EQC) stock price and investment outlook.

, source: Nasdaq

Cash Basis NOI from non-same properties for all periods presented includes the operations of disposed properties. We consider these supplemental non-GAAP financial measures to be appropriate ...

, source: Insider Monkey

Palm Valley Capital Management, an investment management firm, released the “Palm Valley Capital Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third ...

, source: The Real Deal

Equity Commonwealth notched a $50.2 million impairment loss after offloading office holdings in Austin amid its corporate wind-down following the death of founder Sam Zell last year. The Chicago-based ...

, source: Seeking Alpha

Cash Basis NOI from non-same properties for all periods presented includes the operations of disposed properties. NOI is income from our real estate including lease termination fees received from ...

Equity Commonwealth Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of Equity Commonwealth against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1524M 16.2x 1.3x
ABR Unlock Forecast - 30 Days FREE Trial $2537M 11.9x 0.9x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3979M 18.6x 1.3x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3935M 18.4x 1.3x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4866M 22.8x 1.6x
ACR Unlock Forecast - 30 Days FREE Trial $159M 7.3x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $282M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $191M 8.8x 0.5x
ACR-PD Unlock Forecast - 30 Days FREE Trial $167M 7.7x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8161M 43.9x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2010M 10.8x 0.4x
AGNC Unlock Forecast - 30 Days FREE Trial $10657M 28.2x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26376M 69.8x 2.6x
AGNCM Unlock Forecast - 30 Days FREE Trial $26043M 68.9x 2.5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26824M 71.0x 2.6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26688M 70.6x 2.6x
AGNCP Unlock Forecast - 30 Days FREE Trial $26230M 69.4x 2.5x
AHR Unlock Forecast - 30 Days FREE Trial $6925M x 2.9x
AHT Unlock Forecast - 30 Days FREE Trial $19M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $54M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $51M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $45M x x
AIV Unlock Forecast - 30 Days FREE Trial $3184M -6.0x 34.7x
AJX Unlock Forecast - 30 Days FREE Trial $133M -0.8x 0.5x
AKR Unlock Forecast - 30 Days FREE Trial $2429M 470.2x 1.1x
ALEX Unlock Forecast - 30 Days FREE Trial $1350M 17.3x 1.3x
ALX Unlock Forecast - 30 Days FREE Trial $1270M 34.0x 8.7x
AMH Unlock Forecast - 30 Days FREE Trial $332M 39.2x 0.1x
AMT Unlock Forecast - 30 Days FREE Trial $260015M 201.1x 70.0x
APLE Unlock Forecast - 30 Days FREE Trial $3018M 16.7x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $18269M 55.8x 1.1x
ARI Unlock Forecast - 30 Days FREE Trial $1502M -9.0x 0.8x
ARR Unlock Forecast - 30 Days FREE Trial $1346M -6.0x 0.8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1909M x 1.2x
AVB Unlock Forecast - 30 Days FREE Trial $28649M 24.7x 2.4x
BDN Unlock Forecast - 30 Days FREE Trial $764M -5.2x 0.9x
BFS Unlock Forecast - 30 Days FREE Trial $1199M 27.8x 3.7x
BFS-PD Unlock Forecast - 30 Days FREE Trial $826M 19.2x 2.6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $870M 20.2x 2.7x
BHM Unlock Forecast - 30 Days FREE Trial $227M 83.0x 1.7x
BHR Unlock Forecast - 30 Days FREE Trial $597M -3.1x 2.7x
BHR-PB Unlock Forecast - 30 Days FREE Trial $3269M x 14.5x
BHR-PD Unlock Forecast - 30 Days FREE Trial $4058M x 18.0x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0.6x
BNL Unlock Forecast - 30 Days FREE Trial $3859M 39.0x 1.3x
BRSP Unlock Forecast - 30 Days FREE Trial $751M -6.6x 0.8x
BRT Unlock Forecast - 30 Days FREE Trial $282M -37.6x 1.5x
BRX Unlock Forecast - 30 Days FREE Trial $8640M 25.8x 2.9x
BXMT Unlock Forecast - 30 Days FREE Trial $3301M -17.4x 0.9x
BXP Unlock Forecast - 30 Days FREE Trial $18070M 3661.7x 3.4x
CBL Unlock Forecast - 30 Days FREE Trial $964M 14.7x 3.3x
CCI Unlock Forecast - 30 Days FREE Trial $46333M 36.6x 6.1x
CDP Unlock Forecast - 30 Days FREE Trial $3624M 24.1x 2.4x
CDR-PB Unlock Forecast - 30 Days FREE Trial $244M 44.3x 10.9x
CDR-PC Unlock Forecast - 30 Days FREE Trial $220M 39.8x 9.8x
CHCT Unlock Forecast - 30 Days FREE Trial $443M -220.9x 1.0x
CHMI Unlock Forecast - 30 Days FREE Trial $106M -9.3x 0.5x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $842M x 3.7x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $882M x 3.8x
CHTH Unlock Forecast - 30 Days FREE Trial $603M x 0.9x
CIM Unlock Forecast - 30 Days FREE Trial $1179M 6.1x 0.5x
CIMN Unlock Forecast - 30 Days FREE Trial $2081M 10.8x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2091M 10.9x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1862M 9.7x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $2005M 10.4x 0.8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1915M 9.9x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1995M 10.4x 0.8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1010M x 1.6x
CLDT Unlock Forecast - 30 Days FREE Trial $388M 41.0x 0.5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1101M 116.5x 1.5x
CLPR Unlock Forecast - 30 Days FREE Trial $73M -10.4x -20.5x
CMCT Unlock Forecast - 30 Days FREE Trial $6M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1241M x 0.7x
COLD Unlock Forecast - 30 Days FREE Trial $3925M -26.5x 1.3x
CPT Unlock Forecast - 30 Days FREE Trial $12223M 78.4x 2.7x
CSR Unlock Forecast - 30 Days FREE Trial $1181M -74.6x 1.7x
CTO Unlock Forecast - 30 Days FREE Trial $574M 41.8x 1.0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $730M x 1.3x
CTRE Unlock Forecast - 30 Days FREE Trial $6882M 31.3x 2.1x
CUBE Unlock Forecast - 30 Days FREE Trial $9801M 26.2x 3.5x
CUZ Unlock Forecast - 30 Days FREE Trial $5019M 83.4x 1.1x
CXW Unlock Forecast - 30 Days FREE Trial $2303M 22.1x 1.6x
DEA Unlock Forecast - 30 Days FREE Trial $1029M 65.3x 0.8x
DEI Unlock Forecast - 30 Days FREE Trial $5027M 133.4x 2.5x
DHC Unlock Forecast - 30 Days FREE Trial $1074M -1.7x 0.6x
DHCNI Unlock Forecast - 30 Days FREE Trial $4225M -10.4x 2.3x
DHCNL Unlock Forecast - 30 Days FREE Trial $3981M x 2.0x
DLR Unlock Forecast - 30 Days FREE Trial $65440M 47.3x 2.9x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $8355M 6.0x 0.4x
DLR-PK Unlock Forecast - 30 Days FREE Trial $9314M 6.7x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $8104M 5.9x 0.4x
DOC Unlock Forecast - 30 Days FREE Trial $13697M 83.1x 1.7x
DRH Unlock Forecast - 30 Days FREE Trial $1752M 25.8x 1.1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5413M 79.8x 3.4x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1376M 41.8x 1.8x
DX-PC Unlock Forecast - 30 Days FREE Trial $M x x
EARN Unlock Forecast - 30 Days FREE Trial $212M -11.6x 0.9x
EGP Unlock Forecast - 30 Days FREE Trial $8835M 37.4x 2.6x
ELME Unlock Forecast - 30 Days FREE Trial $1508M -114.5x 1.4x
ELS Unlock Forecast - 30 Days FREE Trial $12893M 25.8x 7.5x
EPR Unlock Forecast - 30 Days FREE Trial $0M 18.4x 0.0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PG Unlock Forecast - 30 Days FREE Trial $M x x
EPRT Unlock Forecast - 30 Days FREE Trial $5953M 26.6x 1.6x
EQC Unlock Forecast - 30 Days FREE Trial $177M 2.3x 0.1x
EQIX Unlock Forecast - 30 Days FREE Trial $78255M 78.7x 5.6x
EQR Unlock Forecast - 30 Days FREE Trial $25472M 28.0x 2.3x
ESRT Unlock Forecast - 30 Days FREE Trial $0M 52.3x 0.0x
ESS Unlock Forecast - 30 Days FREE Trial $17938M 22.4x 3.2x
EXR Unlock Forecast - 30 Days FREE Trial $33502M 34.3x 2.4x
FBRT Unlock Forecast - 30 Days FREE Trial $1017M 9.3x 0.7x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1885M 17.2x 1.3x
FCPT Unlock Forecast - 30 Days FREE Trial $2603M 24.6x 1.8x
FPI Unlock Forecast - 30 Days FREE Trial $521M 53.4x 0.8x
FR Unlock Forecast - 30 Days FREE Trial $7210M 26.6x 2.7x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $9467M 27.4x 2.9x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1959M 5.7x 0.6x
FSP Unlock Forecast - 30 Days FREE Trial $174M -1.9x 0.3x
FVR Unlock Forecast - 30 Days FREE Trial $508M x 1.4x
GIPR Unlock Forecast - 30 Days FREE Trial $-118M -0.8x 17.0x
GIPRW Unlock Forecast - 30 Days FREE Trial $1M x 0.2x
GLPI Unlock Forecast - 30 Days FREE Trial $14839M 20.7x 3.3x
GMRE Unlock Forecast - 30 Days FREE Trial $533M 51.8x 1.1x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1761M 171.1x 3.5x
GNL Unlock Forecast - 30 Days FREE Trial $1622M -4.5x 0.9x
GPMT Unlock Forecast - 30 Days FREE Trial $146M -0.9x 0.3x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $985M x 1.7x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2673M x 3.1x
HHH Unlock Forecast - 30 Days FREE Trial $3476M -4.8x 1.3x
HIW Unlock Forecast - 30 Days FREE Trial $3658M 27.8x 1.5x
HR Unlock Forecast - 30 Days FREE Trial $5686M -11.5x 1.1x
HST Unlock Forecast - 30 Days FREE Trial $12576M 19.1x 1.9x
HTIA Unlock Forecast - 30 Days FREE Trial $414M -7.6x 0.6x
HTIBP Unlock Forecast - 30 Days FREE Trial $405M -7.3x 0.6x
ICRP Unlock Forecast - 30 Days FREE Trial $81M 7.2x 0.3x
ICR-PA Unlock Forecast - 30 Days FREE Trial $196M 17.3x 0.8x
IHT Unlock Forecast - 30 Days FREE Trial $2M -57.7x 0.6x
ILPT Unlock Forecast - 30 Days FREE Trial $744M -2.3x 1.4x
IMPM Unlock Forecast - 30 Days FREE Trial $2M x x
INN Unlock Forecast - 30 Days FREE Trial $903M 104.9x 1.0x
INN-PE Unlock Forecast - 30 Days FREE Trial $3414M 396.4x 3.8x
INN-PF Unlock Forecast - 30 Days FREE Trial $3372M 391.5x 3.8x
IOR Unlock Forecast - 30 Days FREE Trial $75M 12.5x 0.6x
IRET Unlock Forecast - 30 Days FREE Trial $317M 16.7x 0.5x
IRM Unlock Forecast - 30 Days FREE Trial $29130M 202.7x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $4299M 154.9x 1.3x
IVR Unlock Forecast - 30 Days FREE Trial $529M 13.1x 0.8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1632M 40.3x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2335M 20.9x 1.3x
JBGS Unlock Forecast - 30 Days FREE Trial $1327M -11.3x 0.7x
KBSR Unlock Forecast - 30 Days FREE Trial $21M x 0.1x
KIM Unlock Forecast - 30 Days FREE Trial $15495M 25.9x 1.5x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14826M 24.8x 1.4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $15178M 25.4x 1.4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $41959M 70.2x 4.0x
KRC Unlock Forecast - 30 Days FREE Trial $5313M 24.2x 1.0x
KREF Unlock Forecast - 30 Days FREE Trial $700M 952.5x 0.6x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1409M x 1.1x
KRG Unlock Forecast - 30 Days FREE Trial $5156M 27.6x 1.6x
LADR Unlock Forecast - 30 Days FREE Trial $0M 15.1x 0.0x
LAMR Unlock Forecast - 30 Days FREE Trial $13196M 30.0x 14.6x
LAND Unlock Forecast - 30 Days FREE Trial $373M -54.4x 0.5x
LANDM Unlock Forecast - 30 Days FREE Trial $900M -119.7x 1.3x
LANDO Unlock Forecast - 30 Days FREE Trial $723M -104.0x 1.1x
LANDP Unlock Forecast - 30 Days FREE Trial $722M -103.5x 1.1x
LFT Unlock Forecast - 30 Days FREE Trial $122M 8.6x 0.5x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1131M 79.4x 4.9x
LINE Unlock Forecast - 30 Days FREE Trial $10850M x 1.3x
LOAN Unlock Forecast - 30 Days FREE Trial $62M 11.2x 1.4x
LTC Unlock Forecast - 30 Days FREE Trial $1827M 22.0x 1.9x
LXP Unlock Forecast - 30 Days FREE Trial $2754M 31.5x 1.3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14076M 160.9x 6.8x
MAA Unlock Forecast - 30 Days FREE Trial $17450M 30.5x 3.0x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6948M 12.2x 1.2x
MAC Unlock Forecast - 30 Days FREE Trial $4754M -64.7x 1.8x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8.9x 1.1x
MDRRP Unlock Forecast - 30 Days FREE Trial $28M -16.5x 2.3x
MDV Unlock Forecast - 30 Days FREE Trial $219M -24.6x 1.3x
MDV-PA Unlock Forecast - 30 Days FREE Trial $364M x 2.2x
MFA Unlock Forecast - 30 Days FREE Trial $1064M 8.3x 0.6x
MFAN Unlock Forecast - 30 Days FREE Trial $2651M 20.6x 1.5x
MFAO Unlock Forecast - 30 Days FREE Trial $2662M 20.7x 1.5x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2288M 17.8x 1.3x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2552M 19.9x 1.4x
MITN Unlock Forecast - 30 Days FREE Trial $757M 16.3x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $753M 16.2x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $232M 5.0x 0.4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $685M 14.8x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $672M 14.5x 1.3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $750M 16.2x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $133M x 2.0x
MPW Unlock Forecast - 30 Days FREE Trial $2906M -1.3x 0.6x
NHHS Unlock Forecast - 30 Days FREE Trial $340M 3.0x 1.4x
NHI Unlock Forecast - 30 Days FREE Trial $3675M 25.7x 2.5x
NHPAP Unlock Forecast - 30 Days FREE Trial $452M x 0.7x
NHPBP Unlock Forecast - 30 Days FREE Trial $454M x 0.7x
NLCP Unlock Forecast - 30 Days FREE Trial $292M 11.2x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $439M x 0.9x
NLY Unlock Forecast - 30 Days FREE Trial $13285M -22.9x 1.0x
NNN Unlock Forecast - 30 Days FREE Trial $8147M 20.7x 1.9x
NREF Unlock Forecast - 30 Days FREE Trial $269M -28.2x 2.5x
NREF-PA Unlock Forecast - 30 Days FREE Trial $M x x
NSA Unlock Forecast - 30 Days FREE Trial $2861M 26.1x 2.8x
NTST Unlock Forecast - 30 Days FREE Trial $1529M 1247.7x 1.2x
NXDT Unlock Forecast - 30 Days FREE Trial $181M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $681M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $878M 16.6x 2.5x
NYC Unlock Forecast - 30 Days FREE Trial $35M -0.1x 0.5x
NYMT Unlock Forecast - 30 Days FREE Trial $684M 11.0x 0.5x
NYMTG Unlock Forecast - 30 Days FREE Trial $2313M 37.2x 1.7x
NYMTI Unlock Forecast - 30 Days FREE Trial $2322M 37.4x 1.7x
NYMTL Unlock Forecast - 30 Days FREE Trial $2059M 33.1x 1.5x
NYMTM Unlock Forecast - 30 Days FREE Trial $2315M 37.3x 1.7x
NYMTN Unlock Forecast - 30 Days FREE Trial $2003M 32.2x 1.5x
NYMTZ Unlock Forecast - 30 Days FREE Trial $1660M 26.7x 1.2x
O Unlock Forecast - 30 Days FREE Trial $55299M 60.4x 1.4x
OHI Unlock Forecast - 30 Days FREE Trial $10939M 27.3x 2.3x
OLP Unlock Forecast - 30 Days FREE Trial $501M 25.4x 1.7x
ONL Unlock Forecast - 30 Days FREE Trial $170M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $897M 140.0x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3935M 36.6x 7.3x
PCH Unlock Forecast - 30 Days FREE Trial $3299M 79.2x 1.7x
PCOK Unlock Forecast - 30 Days FREE Trial $180M x 5.5x
PEB Unlock Forecast - 30 Days FREE Trial $1443M -21.5x 0.6x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2468M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2532M x 1.0x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2464M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2230M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $5659M 82.2x 2.5x
PGRE Unlock Forecast - 30 Days FREE Trial $1392M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $265M 169.3x 1.2x
PKST Unlock Forecast - 30 Days FREE Trial $518M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $119249M 34.6x 2.3x
PLDGP Unlock Forecast - 30 Days FREE Trial $58098M 16.9x 1.1x
PLYM Unlock Forecast - 30 Days FREE Trial $705M 59.5x 1.2x
PMT Unlock Forecast - 30 Days FREE Trial $1076M 10.2x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2111M 20.1x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2094M 19.9x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1630M 15.5x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2221M 21.1x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2213M 21.0x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2206M 21.0x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $52461M 29.0x 5.6x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3883M 2.1x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3791M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4228M 2.3x 0.5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3583M 2.0x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3469M 1.9x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3552M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3421M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3052M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2864M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2883M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2953M 1.6x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2903M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2955M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3031M 1.7x 0.3x
PSTL Unlock Forecast - 30 Days FREE Trial $0M 147.2x 0.0x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.6x
PW-PA Unlock Forecast - 30 Days FREE Trial $13M x 2.1x
RC Unlock Forecast - 30 Days FREE Trial $769M -13.0x 0.4x
RCB Unlock Forecast - 30 Days FREE Trial $4373M -44.3x 2.4x
RCC Unlock Forecast - 30 Days FREE Trial $4448M -45.2x 2.4x
RCD Unlock Forecast - 30 Days FREE Trial $4253M x 2.3x
RC-PC Unlock Forecast - 30 Days FREE Trial $2970M x 1.6x
RC-PE Unlock Forecast - 30 Days FREE Trial $2848M x 1.6x
REFI Unlock Forecast - 30 Days FREE Trial $279M 8.1x 0.9x
REG Unlock Forecast - 30 Days FREE Trial $13312M 22.1x 2.0x
REGCO Unlock Forecast - 30 Days FREE Trial $4284M x 0.6x
REGCP Unlock Forecast - 30 Days FREE Trial $4392M x 0.7x
REXR Unlock Forecast - 30 Days FREE Trial $10721M 33.8x 1.2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5664M 17.8x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5650M 17.8x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $10108M 37.8x 12.6x
RITM Unlock Forecast - 30 Days FREE Trial $7010M 8.7x 0.9x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14226M 17.7x 1.8x
RITM-PB Unlock Forecast - 30 Days FREE Trial $14226M 17.7x 1.8x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13952M 17.4x 1.8x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13746M 17.1x 1.7x
RLJ Unlock Forecast - 30 Days FREE Trial $1166M 20.2x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3755M 65.0x 1.7x
ROIC Unlock Forecast - 30 Days FREE Trial $2248M 45.7x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $129M -0.8x 0.4x
RWT Unlock Forecast - 30 Days FREE Trial $17M 31.3x 0.0x
RWTN Unlock Forecast - 30 Days FREE Trial $70M x 0.1x
RWTO Unlock Forecast - 30 Days FREE Trial $69M x 0.1x
RWTP Unlock Forecast - 30 Days FREE Trial $69M x 0.1x
RYN Unlock Forecast - 30 Days FREE Trial $3676M 36.4x 1.9x
SACC Unlock Forecast - 30 Days FREE Trial $1174M 370.5x 5.3x
SACH Unlock Forecast - 30 Days FREE Trial $54M 21.3x 0.3x
SAFE Unlock Forecast - 30 Days FREE Trial $1217M 11.9x 0.5x
SBAC Unlock Forecast - 30 Days FREE Trial $21249M 24.2x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4605M 25.3x 1.7x
SCCC Unlock Forecast - 30 Days FREE Trial $1183M 361.5x 6.6x
SCCD Unlock Forecast - 30 Days FREE Trial $1029M 304.5x 5.7x
SCCE Unlock Forecast - 30 Days FREE Trial $923M 304.8x 5.1x
SCCF Unlock Forecast - 30 Days FREE Trial $907M 279.9x 5.1x
SCCG Unlock Forecast - 30 Days FREE Trial $911M 325.2x 5.1x
SELF Unlock Forecast - 30 Days FREE Trial $60M 24.0x 1.3x
SEVN Unlock Forecast - 30 Days FREE Trial $163M 10.5x 0.6x
SILA Unlock Forecast - 30 Days FREE Trial $1360M x 1.0x
SITC Unlock Forecast - 30 Days FREE Trial $495M 1.4x 1.0x
SKT Unlock Forecast - 30 Days FREE Trial $4100M 38.7x 6.5x
SLG Unlock Forecast - 30 Days FREE Trial $5175M -33.2x 1.4x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1889M x 0.5x
SOHO Unlock Forecast - 30 Days FREE Trial $18M -1.4x 0.4x
SOHOB Unlock Forecast - 30 Days FREE Trial $322M -21.4x 7.0x
SOHON Unlock Forecast - 30 Days FREE Trial $335M -21.8x 7.3x
SOHOO Unlock Forecast - 30 Days FREE Trial $333M -25.6x 7.2x
SPG Unlock Forecast - 30 Days FREE Trial $142M 23.1x 0.1x
SQFT Unlock Forecast - 30 Days FREE Trial $64M 1.2x 1.8x
SQFTP Unlock Forecast - 30 Days FREE Trial $191M 24.7x 5.4x
SQFTW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
STAG Unlock Forecast - 30 Days FREE Trial $6956M 29.7x 2.0x
STLY Unlock Forecast - 30 Days FREE Trial $20M 32.3x 0.5x
STRW Unlock Forecast - 30 Days FREE Trial $663M 111.4x 42.8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $7848M 21.2x 1.2x
SUI Unlock Forecast - 30 Days FREE Trial $17464M 13.6x 2.4x
SUNS Unlock Forecast - 30 Days FREE Trial $145M 14.5x 0.8x
SVC Unlock Forecast - 30 Days FREE Trial $481M -2.2x 0.7x
TCI Unlock Forecast - 30 Days FREE Trial $412M 62.5x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $202M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $563M x 3.3x
TRTX Unlock Forecast - 30 Days FREE Trial $790M 11.8x 0.7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1477M 22.0x 1.4x
TWO Unlock Forecast - 30 Days FREE Trial $1289M -55.6x 0.6x
TWOD Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PA Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PB Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PC Unlock Forecast - 30 Days FREE Trial $M x x
UDR Unlock Forecast - 30 Days FREE Trial $16632M 126.1x 5.0x
UHT Unlock Forecast - 30 Days FREE Trial $574M 32.0x 3.5x
UMH Unlock Forecast - 30 Days FREE Trial $1289M 42.3x 1.4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63.1x 2.1x
UNIT Unlock Forecast - 30 Days FREE Trial $1760M 49.9x -0.5x
VICI Unlock Forecast - 30 Days FREE Trial $35579M 12.9x 1.3x
VNO Unlock Forecast - 30 Days FREE Trial $9718M 11.1x 1.6x
VNO-PL Unlock Forecast - 30 Days FREE Trial $4291M 4.9x 0.7x
VNO-PM Unlock Forecast - 30 Days FREE Trial $4233M 4.8x 0.7x
VNO-PN Unlock Forecast - 30 Days FREE Trial $4226M 4.8x 0.7x
VNO-PO Unlock Forecast - 30 Days FREE Trial $3528M 4.0x 0.6x
VNORP Unlock Forecast - 30 Days FREE Trial $12723M 14.5x 2.1x
VRE Unlock Forecast - 30 Days FREE Trial $1836M -32.8x 1.7x
VTR Unlock Forecast - 30 Days FREE Trial $32620M 170.6x 2.8x
WELL Unlock Forecast - 30 Days FREE Trial $114068M 101.0x 3.2x
WHLR Unlock Forecast - 30 Days FREE Trial $-9M -4.1x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $-193M -86.0x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $-774M -344.1x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $-22M -9.8x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $15149M 45.1x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $693M 20.6x 1.6x
WY Unlock Forecast - 30 Days FREE Trial $18733M 67.1x 2.0x

Frequently Asked Questions - Equity Commonwealth Stock Forecast

How accurate are Equity Commonwealth stock predictions?

Our AI model demonstrates 17% historical accuracy for EQC predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Equity Commonwealth stock price forecasts?

Our analysis considers Equity Commonwealth's financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Equity Commonwealth a good investment in 2025?

Based on our AI analysis, Equity Commonwealth shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Equity Commonwealth forecasts updated?

Equity Commonwealth stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Equity Commonwealth Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Equity Commonwealth stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...